Cargando…
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors
Histone deacetylases are important targets for cancer therapeutics, but their regulation is poorly understood. Our data show coordinated transcription of HDAC1 and HDAC2 in lung cancer cell lines, but suggest HDAC2 protein expression is cell-context specific. Through an unbiased siRNA screen we foun...
Autores principales: | Sacco, Joseph J., Kenyani, Jenna, Butt, Zohra, Carter, Rachel, Chew, Hui Yi, Cheeseman, Liam P., Darling, Sarah, Denny, Michael, Urbé, Sylvie, Clague, Michael J., Coulson, Judy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537048/ https://www.ncbi.nlm.nih.gov/pubmed/25970771 |
Ejemplares similares
-
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
por: Sacco, J J, et al.
Publicado: (2014) -
The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit
por: Faronato, Monica, et al.
Publicado: (2013) -
The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity
por: Fielding, Andrew B., et al.
Publicado: (2018) -
BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
por: Barnett, Sarah E., et al.
Publicado: (2023) -
Integration of cellular ubiquitin and membrane traffic systems: focus on deubiquitylases
por: Clague, Michael J., et al.
Publicado: (2017)